Wells Fargo
NMTR

Wells Fargo’s 9 Meters Biopharma NMTR Stock Holding History

Wells Fargo’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-353
Closed -$237 – 7788
2023
Q2 		$237 Buy
353
+13
+4% +$11 ﹤0.01% 6652
2023
Q1 		$473 Buy
340
+2
+0.6% +$4 ﹤0.01% 6568
2022
Q4 		$426 Sell
338
-548
-62% -$1.25K ﹤0.01% 6428
2022
Q3 		$3K Sell
886
-100
-10% -$496 ﹤0.01% 6109
2022
Q2 		$4K Sell
986
-1,926
-66% -$18.1K ﹤0.01% 6138
2022
Q1 		$35K Sell
2,912
-3,958
-58% -$54K ﹤0.01% 5809
2021
Q4 		$134K Buy
6,870
+6,508
+1,798% +$146K ﹤0.01% 5486
2021
Q3 		$10K Hold
362
– – ﹤0.01% 6216
2021
Q2 		$8K Sell
362
-93
-20% -$2.28K ﹤0.01% 6218
2021
Q1 		$11K Buy
455
+167
+58% +$5.13K ﹤0.01% 6323
2020
Q4 		$5K Buy
288
+5
+2% +$83 ﹤0.01% 6158
2020
Q3 		$5K Buy
283
+24
+9% +$291 ﹤0.01% 6028
2020
Q2 		$3K Buy
259
+252
+3,600% +$2.84K ﹤0.01% 6069
2020
Q1 		$0 Sell
7
-957
-99% -$12K ﹤0.01% 7023
2019
Q4 		$11K Buy
964
+534
+124% +$8.89K ﹤0.01% 5880
2019
Q3 		$9K Sell
430
-1,168
-73% -$23.6K ﹤0.01% 5964
2019
Q2 		$37K Sell
1,598
-276
-15% -$8.28K ﹤0.01% 5651
2019
Q1 		$73K Buy
1,874
+104
+6% +$4.5K ﹤0.01% 5231
2018
Q4 		$81K Buy
1,770
+231
+15% +$17.1K ﹤0.01% 5380
2018
Q3 		$210K Buy
1,539
+375
+32% +$64.4K ﹤0.01% 4977
2018
Q2 		$549K Buy
+1,164
New +$428K ﹤0.01% 4377

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Wells Fargo's NMTR Position: Q3 2023 in Review

Wells Fargo sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 353 shares — an estimated $237 sold.

Wells Fargo first reported a position in NMTR in Q2 2018 and held it in 21 quarters. The position peaked at $549K in Q2 2018. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Wells Fargo reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Wells Fargo sold 353 9 Meters Biopharma shares in Q3 2023, an estimated $237.
  • Wells Fargo first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 21 quarters.
  • Wells Fargo's 9 Meters Biopharma position peaked at $549K in Q2 2018.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.